129 related articles for article (PubMed ID: 34839998)
1. Branched alkyl of phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as unique cytochrome P450 1A1-activated antimitotic prodrugs: Biological evaluation and mechanism of bioactivation.
Bouzriba C; Chavez Alvarez AC; Gagné-Boulet M; Ouellette V; Lacroix J; Côté MF; C-Gaudreault R; Fortin S
Eur J Med Chem; 2022 Feb; 229():114003. PubMed ID: 34839998
[TBL] [Abstract][Full Text] [Related]
2. 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells.
Chavez Alvarez AC; Zarifi Khosroshahi M; Côté MF; Gagné-Boulet M; Fortin S
Bioorg Med Chem; 2018 Oct; 26(18):5045-5052. PubMed ID: 30201525
[TBL] [Abstract][Full Text] [Related]
3. Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells.
Fortin S; Charest-Morin X; Turcotte V; Lauvaux C; Lacroix J; Côté MF; Gobeil S; C-Gaudreault R
J Med Chem; 2017 Jun; 60(12):4963-4982. PubMed ID: 28535350
[TBL] [Abstract][Full Text] [Related]
4. Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver Microsomes.
Chavez Alvarez AC; Bouzriba C; Moreau E; Auzeloux P; Besse S; Ouellette V; Zarifi Khosroshahi M; Côté MF; Pilote S; Miot-Noirault E; Chezal JM; Simard C; C-Gaudreault R; Fortin S
J Med Chem; 2023 Feb; 66(4):2477-2497. PubMed ID: 36780426
[TBL] [Abstract][Full Text] [Related]
5. 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamide salts: Novel hydrosoluble prodrugs of antimitotics selectively bioactivated by the cytochrome P450 1A1 in breast cancer cells.
Ouellette V; Chavez Alvarez AC; Bouzriba C; Hamel-Côté G; Fortin S
Bioorg Chem; 2023 Nov; 140():106820. PubMed ID: 37672952
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the time-dependent antiproliferative activity and liver microsome stability of 3 phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as promising CYP1A1-dependent antimicrotubule prodrugs.
Zarifi Khosroshahi M; Corin Chavez Alvarez A; Gagné-Boulet M; C-Gaudreault R; Gobeil S; Fortin S
J Pharm Pharmacol; 2020 Feb; 72(2):249-258. PubMed ID: 31729035
[TBL] [Abstract][Full Text] [Related]
7. Phenyl 4-(2-oxopyrrolidin-1-yl)benzenesulfonates and phenyl 4-(2-oxopyrrolidin-1-yl)benzenesulfonamides as new antimicrotubule agents targeting the colchicine-binding site.
Gagné-Boulet M; Bouzriba C; Chavez Alvarez AC; Fortin S
Eur J Med Chem; 2021 Mar; 213():113136. PubMed ID: 33472119
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of new 2,6-difluorinated phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new antimicrotubule agents.
Bouzriba C; Gagné-Boulet M; Chavez Alvarez AC; Ouellette V; Laverdière I; Fortin S
Bioorg Chem; 2024 May; 146():107299. PubMed ID: 38547722
[TBL] [Abstract][Full Text] [Related]
9. Preparation and biological evaluation of new antimicrotubule agents: Modification of the imidazolidin-2-one moiety of phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates.
Gagné-Boulet M; Bouzriba C; Chavez Alvarez AC; Fortin S
Chem Biol Drug Des; 2022 Feb; 99(2):187-196. PubMed ID: 34623027
[TBL] [Abstract][Full Text] [Related]
10. Modification of the phenyl ring B of phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates by pyridinyl moiety leads to novel antimitotics targeting the colchicine-binding site.
Ouellette V; Bouzriba C; Chavez Alvarez AC; Hamel-Côté G; Fortin S
Bioorg Med Chem Lett; 2024 Jun; 105():129745. PubMed ID: 38614151
[TBL] [Abstract][Full Text] [Related]
11. Substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure-activity relationships.
Fortin S; Wei L; Moreau E; Lacroix J; Côté MF; Petitclerc E; Kotra LP; Gaudreault RC
Eur J Med Chem; 2011 Nov; 46(11):5327-42. PubMed ID: 21920638
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterisation and biological evaluation of new N-phenyl amidobenzenesulfonates and N-phenyl ureidobenzenesulfonates inducing DNA double-strand breaks. Part 3. Modulation of ring A.
Gagné-Boulet M; Bouzriba C; Godard M; Fortin S
Eur J Med Chem; 2018 Jul; 155():681-694. PubMed ID: 29936355
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel N-phenyl ureidobenzenesulfonate derivatives as potential anticancer agents. Part 2. Modulation of the ring B.
Gagné-Boulet M; Moussa H; Lacroix J; Côté MF; Masson JY; Fortin S
Eur J Med Chem; 2015 Oct; 103():563-73. PubMed ID: 26408815
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biological evaluation, and structure-activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new tubulin inhibitors mimicking combretastatin A-4.
Fortin S; Wei L; Moreau E; Lacroix J; Côté MF; Petitclerc E; Kotra LP; C-Gaudreault R
J Med Chem; 2011 Jul; 54(13):4559-80. PubMed ID: 21604746
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological evaluation, and structure-activity relationships of novel substituted N-phenyl ureidobenzenesulfonate derivatives blocking cell cycle progression in S-phase and inducing DNA double-strand breaks.
Turcotte V; Fortin S; Vevey F; Coulombe Y; Lacroix J; Côté MF; Masson JY; C-Gaudreault R
J Med Chem; 2012 Jul; 55(13):6194-208. PubMed ID: 22694057
[TBL] [Abstract][Full Text] [Related]
16. Optimization of antiproliferative activity of substituted phenyl 4-(2-oxoimidazolidin-1-yl) benzenesulfonates: QSAR and CoMFA analyses.
Masand VH; Mahajan DT; Alafeefy AM; Bukhari SN; Elsayed NN
Eur J Pharm Sci; 2015 Sep; 77():230-7. PubMed ID: 26066412
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.
Bart AG; Morais G; Vangala VR; Loadman PM; Pors K; Scott EE
Drug Metab Dispos; 2022 Jan; 50(1):49-57. PubMed ID: 34607808
[TBL] [Abstract][Full Text] [Related]
18. The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells.
Ruparelia KC; Lodhi S; Ankrett DN; Wilsher NE; Arroo RRJ; Potter GA; Beresford KJM
Bioorg Med Chem Lett; 2019 Jun; 29(11):1403-1406. PubMed ID: 30935796
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative evaluation of certain 4-anilino-8-methoxy-2-phenylquinoline and 4-anilino-8-hydroxy-2-phenylquinoline derivatives.
Chen YL; Huang CJ; Huang ZY; Tseng CH; Chang FS; Yang SH; Lin SR; Tzeng CC
Bioorg Med Chem; 2006 May; 14(9):3098-105. PubMed ID: 16412647
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 1-benzyl-N-(2-(phenylamino)pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamides as antimitotic agents.
Prasad B; Lakshma Nayak V; Srikanth PS; Baig MF; Subba Reddy NV; Babu KS; Kamal A
Bioorg Chem; 2019 Mar; 83():535-548. PubMed ID: 30472555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
